Related Experiment Video
Updated: Jan 29, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Targeting the Notch receptor dimerization domain to inhibit Notch signalling-A new avenue of therapeutics
1School of Health Sciences, The University of Note Dame Australia, Fremantle, Australia.
Abstract:
Notch signalling is an evolutionarily conserved signalling pathway that directs cell growth and differentiation across multiple tissue types, and its regulation must be controlled across the lifespan. Aberrant Notch signalling due to genetic mutations that occur within the negative regulatory region of the Notch 1 gene is linked to the development of acute T-cell leukaemia in humans. This discovery has led to a concerted effort to understand how Notch receptor signalling is regulated in mammalian cells. Liu et al. have developed a range of novel peptide inhibitors that target the heterodimerization domain within the negative regulatory region of the Notch receptor. They show that the peptide inhibitors are specific to a Notch receptor paralogue. The possible biological and therapeutic consequences are discussed.
Insights
Researchers developed novel peptide inhibitors targeting Notch signalling, a pathway crucial for cell growth and differentiation. These inhibitors show specificity for Notch receptor paralogues, offering potential therapeutic strategies for related diseases like T-cell leukaemia.
Area of Science:
- Cellular biology
- Molecular signalling
- Cancer biology
Background:
- Notch signalling is vital for cell growth and differentiation, conserved across species.
- Mutations in the Notch 1 gene's negative regulatory region are linked to acute T-cell leukaemia.
- Understanding Notch receptor regulation is critical for therapeutic development.
Purpose of the Study:
- To develop novel peptide inhibitors targeting the Notch receptor.
- To investigate the specificity of these inhibitors.
- To explore the therapeutic potential of inhibiting Notch signalling.
Main Methods:
- Design and synthesis of novel peptide inhibitors.
- Targeting the heterodimerization domain within the Notch receptor's negative regulatory region.
- Assessing inhibitor specificity across Notch receptor paralogues.
Main Results:
- Novel peptide inhibitors were successfully developed.
- The peptide inhibitors demonstrated specificity for a particular Notch receptor paralogue.
- The study provides a basis for understanding the biological and therapeutic implications of these inhibitors.
Conclusions:
- Peptide inhibitors targeting the Notch receptor's negative regulatory region can be specific.
- This specificity opens avenues for targeted therapies in Notch-related diseases.
- Further research is warranted to explore the full therapeutic potential.
More Related Videos
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Internal Receptors
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Signal Sequences and Sorting Receptors
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...

